北美内部神经刺激设备市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 免费样本报告 免费样本报告 购买前请咨询 提前咨询 立即购买 立即购买

北美内部神经刺激设备市场 – 行业趋势和 2029 年预测

  • Medical Devices
  • Published Report
  • Sep 2022
  • North America
  • 350 页面
  • 桌子數: 154
  • 图号: 33

通过敏捷供应链咨询解决关税挑战

供应链生态系统分析现已成为 DBMR 报告的一部分

北美内部神经刺激设备市场,按产品类型(脊髓刺激 (SCS)、深部脑刺激、迷走神经刺激、骶神经刺激和胃电刺激)、分销渠道(直接招标和第三方服务提供商)划分 - 行业趋势和预测到 2029 年。

北美内部神经刺激设备市场

北美内部神经刺激设备市场分析与洞察

作为附加疗法的内部神经刺激装置的需求增加、神经系统疾病患病率和发病率的增加、神经刺激装置的资金增加、内部神经刺激装置的技术进步以及产品审批的增加,预计将推动市场增长。

北美内部神经刺激设备市场

北美内部神经刺激设备市场

市场参与者的战略举措以及公共和私人市场参与者对内部神经刺激设备的资金增加预计将为市场增长创造机会。然而,缺乏熟练和训练有素的内部神经刺激设备专家预计将抑制该领域的增长。替代成像设备的可用性预计将对市场增长构成挑战。

Data Bridge Market Research 分析,在 2022 年至 2029 年的预测期内,北美内部神经刺激设备市场将以 20.5% 的复合年增长率增长,达到 98.9811 亿美元。

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制至 2019 - 2024)

定量单位

收入(百万美元),定价(美元)

涵盖的领域

按产品类型(脊髓刺激 (SCS)、深部刺激、迷走神经刺激、骶神经刺激和电刺激)、分销渠道(直接招标和第三方服务提供商)

覆盖国家

美国、加拿大和墨西哥

涵盖的市场参与者

Medtronic、LivaNova PLC、Abbott、ONWARD、Sequana Medical NV、CIRTEC、Valencia Technologies、Nalu Medical, Inc.、NEVRO CORP.、Stimwave LLC、MicroTransponder Inc.、Newronika SpA、Microsemi(Microchip Technology Inc. 的子公司)、Boston Scientific Corporation、Inspire Medical Systems, Inc、Integer Holdings Corporation、BlueWind Medical、Micro-Leads、Axonics, Inc. 等

市场定义

内部神经刺激装置是一种通过手术放置的装置。它通过一根或多根细线(称为导线)向脊柱附近的硬膜外腔传送轻微的电信号。神经刺激通过干扰脊髓和大脑之间传递的疼痛信号来缓解疼痛。

神经刺激装置包括侵入式和非侵入式方法,涉及电刺激以驱动电路内的神经功能。对内部神经刺激装置的需求增加是由于神经刺激装置的下一代技术进步,为全球前所未有的大量受神经和精神疾病影响的患者提供了急需的治疗缓解。现代神经调节疗法的兴起已经持续了半个多世纪,其中充满了偶然的发现和技术进步,导致了不同的神经刺激策略。在过去的二十年里,医疗器械技术的创新已经开始以更快的速度推动这些神经刺激系统的发展。

患者使用的便捷内部神经刺激装置是迷走神经刺激器。迷走神经刺激器使用一种装置通过电脉冲刺激迷走神经。目前,植入式迷走神经刺激器已获得 FDA 批准,用于治疗癫痫和抑郁症。身体两侧各有一条迷走神经,从脑干穿过颈部到胸部和腹部。未来,闭环刺激和远程编程等软件进步将使内部神经刺激器成为一种更加个性化和易于使用的技术。内部神经刺激器的未来有望进一步改善生活质量。

北美内部神经刺激设备市场动态

本节旨在了解市场驱动因素、机遇、限制因素和挑战。下文将详细讨论所有这些内容:

驱动程序

  • 提高对慢性尿失禁治疗的认识

患者和医疗保健提供者的意识增强以及节制服务普及是改善护理服务的关键因素。尿失禁 (UI) 和下尿路症状 (LUTS) 很常见,给所有年龄段的许多女性和男性带来痛苦。神经病学中植入式内部神经刺激装置的意识增强意味着研发相关投资的增加,用于发现和开发先进的无痛内部神经刺激装置,这有望促进市场增长。

  • 内部神经刺激装置的技术进步

内部神经刺激装置的技术发展利用神经调节技术,该技术可直接将电或药物输送到目标区域。神经调节和内部神经刺激装置及治疗改变了人们的生活。技术发展以可编程的方式调节神经功能并调节紊乱的神经活动。结果可以以最小的误差交付。

例如,

  • 2022 年 5 月,ONWARD 推出了 ARC 植入式脉冲发生器 (IPG),用于刺激脊髓,帮助 SCI 患者和其他影响行动能力的疾病患者恢复运动和自主神经功能

内部神经刺激装置的获批将使该装置被宣布为安全使用并准备上市后审批。这将导致 MRI 机器在美国人口统计的发展中市场的供应和分销。因此,产品审批数量的增加预计将推动北美内部神经刺激装置市场的增长。

机会

  • 内部神经刺激装置的最新产品开发

由于神经血管疾病(如癫痫、脑卒中和脑动脉瘤)的患病率不断上升,以及目标患者疾病的严重程度(如放电和周围疾病)不断增加,对有效神经血管疗法的需求稳步增长,北美内部神经刺激设备市场的增长曲线呈上升趋势。由于这些疾病的患病率不断上升,人们对其严重性的认识也不断提高,因此各种设备或装置正在制造或进行临床试验。

因此,近年来的产品开发显示了这些技术的潜力,而在这个市场工作的公司正在努力获得更先进的产品,这将成为市场增长的机会。

  • 主要市场参与者的战略举措

由于研发水平的提高以及北美内部神经刺激设备市场的增长以及对创新药物的需求,市场对内部神经刺激设备的需求正在增加。因此,顶级市场参与者实施了一项新战略,开发新设备和设备,与市场中的其他参与者合作,并改善业务运营和盈利能力。

  • 2021 年 1 月,波士顿科学公司开始向美国运送其 Wave Writer Alpha 脊髓触发框架

因此,全球神经刺激设备市场中的公司正在采取合作,以先进的技术丰富的产品来增加其产品组合,从而在各个方面促进其业务。因此,主要市场参与者的战略举措预计将为北美内部神经刺激设备市场的市场参与者提供重大机遇。

限制/挑战

  • 植入这些设备的相关风险

医疗植入物存在多种危险,包括安装或移除过程中的手术、感染和植入物故障。植入物中使用的材料可能会引起某些人的反应。每项外科手术都有一定的风险。这些风险包括手术部位的瘀伤、不适、肿胀和发红。因此,这将在一定程度上阻碍植入设备的发展。因此,人们对神经刺激植入物相关风险上升的认识不断提高,可能会阻碍市场的增长。

例如,

  • 植入失败
  • 放置或移除期间的手术风险
  • 植入式设备劫持的风险
  • 感染率上升
  • 植入物中使用的材料可能会对患者产生不良反应

上述风险可能会阻碍内部神经刺激设备市场的增长,因为与患者有关的风险至关重要。因此,对植入式设备的潜在风险的认识对北美内部神经刺激设备市场来说是一个挑战。

  • 缺乏熟练的医疗保健专业人员

神经刺激装置是一种可植入的可编程医疗设备,可向患者大脑、脊髓或周围神经系统的特定部位提供电刺激,以帮助治疗各种疾病,包括慢性疼痛、运动障碍、癫痫和帕金森病。这些强大的技术需要高成本的开发程序和熟练的专业人员来处理敏感设备。植入后每 3-6 年应更换一次,这是一个成本负担,通常大多数患者都需要自掏腰包。

由于价格高昂、报销环境薄弱以及缺乏熟练的医疗资源,只有相对较少的贫穷国家的患者能够负担得起神经治疗费用。因此,医疗机构不愿在新颖或尖端技术上投入资金,从而限制了市场的扩张。因此,这些挑战可能会阻碍市场的增长。

COVID-19 对北美内部神经刺激设备市场的影响

在疫情期间,北美内部神经刺激设备行业专注于结合使用生物学和信息技术。在 COVID-19 疫情期间,除了内部神经刺激设备的常见治疗挑战外,还增加了新的治疗挑战。植入鞘内输液装置的患者需要重新填充泵以避免戒断综合征。植入神经刺激装置的患者可能需要检查以防感染、伤口裂开或导线移位。

最新动态

  • 2022 年 1 月,美敦力获得了美国食品药品监督管理局 (FDA) 的 Intellis 可充电神经刺激器产品批准,这是一种用于治疗糖尿病周围神经病变引起的慢性疼痛的脊髓刺激疗法。该产品获得批准后,脊髓刺激产品类别中又增加了一款新产品。预计该批准将在美国市场上市后获得批准
  • 2022 年 7 月,雅培获得美国食品药品监督管理局 (FDA) 批准,其 Infinity 深部脑刺激系统可用于治疗抑郁症。该批准使得上市前和上市后审批数量增加,并增加了新产品到产品组合中

北美内部神经刺激设备市场范围

北美内部神经刺激设备市场分为产品类型和分销渠道。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

产品类型

  • 脊髓刺激(SCS)
  • 深部脑刺激
  • 迷走神经刺激
  • 骶神经刺激
  • 胃电刺激

根据产品类型,北美内部神经刺激设备市场分为脊髓刺激(SCS)、深部脑刺激、迷走神经刺激、骶神经刺激、胃电刺激。

分销渠道

  • 直接招标
  • 第三方服务提供商

内部神经刺激设备市场

根据分销渠道,北美内部神经刺激设备市场分为直接投标和第三方服务提供商。

北美内部神经刺激设备市场区域分析/见解

对北美内部神经刺激设备市场进行了分析,并按国家、产品类型和分销渠道提供了各地区市场规模洞察和趋势,如上所述。

北美内部神经刺激设备市场涵盖的一些国家包括美国、加拿大和墨西哥。由于研发活动的增加、神经病学和尿失禁治疗中对内部神经刺激设备的综合需求以及公私部门对神经刺激设备的资助增加,美国预计将主导市场。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场法规变化。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战,这些品牌影响销售渠道。

竞争格局和北美内部神经刺激设备市场份额分析

北美内部神经刺激设备市场竞争格局提供了有关竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对北美内部神经刺激设备市场的关注有关。

北美内部神经刺激设备市场的一些主要参与者包括美敦力、LivaNova PLC、雅培、ONWARD、Sequana Medical NV、CIRTEC、Valencia Technologies、Nalu Medical, Inc.、NEVRO CORP.、Stimwave LLC、MicroTransponder Inc.、Newronika SpA、Microsemi(Microchip Technology Inc. 的子公司)、波士顿科学公司、Inspire Medical Systems, Inc、Integer Holdings Corporation、BlueWind Medical、Micro-Leads、Axonics, Inc. 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHIC SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 RESEARCH METHODOLOGY

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 DBMR MARKET POSITION GRID

2.8 THE CATEGORY VS TIME GRID

2.9 SECONDARY SOURCES

2.1 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL

4.2 PORTER'S FIVE FORCES MODEL

4.3 PIPELINE ANALYSIS FOR INTERNAL NEUROSTIMULATION DEVICES MARKET

5 REGULATIONS OF NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET

6 EPIDEMIOLOGY OF DISEASES

6.1 INCIDENCE OF ISCHEMIA

6.2 INCIDENCE OF PARKINSON'S DISEASE

6.3 INCIDENCE OF FAILED BACK SYNDROME

6.4 INCIDENCE OF TREMOR

6.5 INCIDENCE OF DEPRESSION

6.6 INCIDENCE OF URINE INCONTINENCE

6.7 INCIDENCE OF FECAL INCONTINENCE

6.8 INCIDENCE RATE OF EPILEPSY

6.9 INCIDENCE OF GASTROPARESIS

6.1 PREVALENCE OF OBESITY

7 EPIDEMIOLOGY OF NEUROSTIMULATION PROCEDURES

7.1 NUMBER OF SPINAL CORD STIMULATION (SCS) PROCEDURES

7.1.1 NUMBER OF TEST PROCEDURES

7.1.2 NUMBER OF IMPLANTATION PROCEDURES

7.2 NUMBER OF DEEP BRAIN STIMULATION PROCEDURES

7.3 NUMBER OF VAGUS NERVE STIMULATION PROCEDURES

7.4 NUMBER OF SACRAL NEVER STIMULATION PROCEDURES

7.5 NUMBER OF TRANSCRANIAL MAGNETIC STIMULATION (TMS) PROCEDURES

7.6 NUMBER OF INTERMITTENT THETA BURST STIMULATION (ITBS) PROCEDURES

7.7 NUMBER OF TRANSCRANIAL DIRECT ELECTRICAL STIMULATION (TDCS) PROCEDURES

8 MARKET OVERVIEW

8.1 DRIVERS

8.1.1 RISE IN PREVALENCE AND INCIDENCE OF NEUROLOGICAL DISORDERS

8.1.2 DEMAND FOR INTERNAL NEUROSTIMULATION DEVICES AS A ADD ON THERAPY

8.1.3 INCREASED FUNDING FOR THE NEUROSTIMULATION DEVICES

8.1.4 TECHNOLOGICAL ADVANCEMENTS IN THE INTERNAL NEUROSTIMULATION DEVICES

8.1.5 RISE IN PRODUCT APPROVALS

8.2 RESTRAINTS

8.2.1 RISE IN COST OF THE DEEP BRAIN STIMULATION DEVICES

8.2.2 RISKS NOTICED WHILE USING THE INTERNAL NEUROSTIMULATION DEVICES

8.2.3 RISE IN PRODUCT RECALL

8.2.4 AVAILABILITY OF ALTERNATE IMAGING DIAGNOSTIC DEVICES

8.3 OPPORTUNITIES

8.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER

8.3.2 RECENT PRODUCT DEVELOPMENTS IN THE INTERNAL NEUROSTIMULATION DEVICES

8.3.3 DEMAND FOR MINIMALLY INVASIVE SURGERY

8.4 CHALLENGES

8.4.1 RISKS ASSOCIATED WITH THE IMPLANTATION OF THESE DEVICES

8.4.2 LACK OF SKILLED HEALTHCARE PROFESSIONALS

9 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE

9.1 OVERVIEW

9.2 SPINAL CORD STIMULATION

9.2.1 SPINAL CORD STIMULATION, BY TYPE

9.2.1.1 BATTERY

9.2.1.1.1 RECHARGEABLE

9.2.1.1.2 NON-RECHARGEABLE

9.2.1.2 LEAD

9.2.1.2.1 PERCUTANEOUS

9.2.1.2.2 PADDLE

9.2.2 SPINAL CORD STIMULATION, BY APPLICATION

9.2.2.1 ISCHEMIA

9.2.2.2 CHRONIC LOW BACK PAIN (CLBP)

9.2.2.3 DIABETIC NEUROPATHY

9.2.2.4 FAILED BACK SYNDROME

9.3 DEEP BRAIN STIMULATION

9.3.1 DEEP BRAIN STIMULATION, BY TYPE

9.3.1.1 SINGLE CHANNEL DEEP BRAIN STIMULATOR

9.3.1.2 DOUBLE CHANNEL DEEP BRAIN STIMULATOR

9.3.1.3 BATTERY

9.3.1.3.1 RECHARGEABLE

9.3.1.3.2 NON-RECHARGEABLE

9.3.1.4 LEAD

9.3.2 DEEP BRAIN STIMULATION, BY APPLICATION

9.3.2.1 PARKINSON’S DISEASE

9.3.2.2 TREMOR

9.3.2.3 DEPRESSION

9.4 SACRAL NERVE STIMULATION

9.4.1 SACRAL NERVE STIMULATION, BY TYPE

9.4.1.1 BATTERY

9.4.1.2 LEAD

9.5 SACRAL NERVE STIMULATION, BY APPLICATION

9.5.1 URINE INCONTINENCE

9.5.2 FECAL INCONTINENCE

9.6 VAGUS NERVE STIMULATION

9.6.1 VAGUS NERVE STIMULATION, BY TYPE

9.6.1.1 BATTERY

9.6.1.2 LEAD

9.6.2 VAGUS NERVE STIMULATION, BY APPLICATION

9.6.2.1 EPILEPSY

9.6.2.2 OTHERS

9.7 GASTRIC ELECTRICAL STIMULATION

9.7.1 GASTRIC ELECTRICAL STIMULATION, BY TYPE

9.7.1.1 BATTERY

9.7.1.2 LEAD

9.7.2 GASTRIC ELECTRICAL STIMULATION, BY APPLICATION

9.7.2.1 GASTROPARESIS

9.7.2.2 OTHERS

10 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT TENDER

10.3 THIRD PARTY PROVIDER

11 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION

11.1 NORTH AMERICA

11.1.1 U.S.

11.1.2 CANADA

11.1.3 MEXICO

12 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 MEDTRONIC (2021)

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.2 BOSTON SCIENTIFIC CORPORATION (2021)

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 ABBOTT (2021)

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 LIVANOVA PLC (2021)

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 NEVRO CORP. (2021)

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENTS

14.6 AXONICS, INC.

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENTS

14.7 ALEVA NEUROTHERAPEUTICS

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 BIONIC VISION TECHNOLOGIES.

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 BLUEWIND MEDICAL

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 BIOINDUCTION

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENT

14.11 CIRTEC

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENTS

14.12 FINETECH MEDICAL

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 GIMER MEDICAL

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENTS

14.14 INSPIRE MEDICAL SYSTEMS, INC.

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT DEVELOPMENTS

14.15 INTEGER HOLDINGS CORPORATION

14.15.1 COMPANY SNAPSHOT

14.15.2 REVENUE ANALYSIS

14.15.3 PRODUCT PORTFOLIO

14.15.4 RECENT DEVELOPMENT

14.16 INBRAIN NEUROELECTRONICS

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENT

14.17 MAINSTAY MEDICAL

14.17.1 COMPANY SNAPSHOT

14.17.2 REVENUE ANALYSIS

14.17.3 PRODUCT PORTFOLIO

14.17.4 RECENT DEVELOPMENTS

14.18 MICROSEMI (A WHOLLY OWNDED SUBSIDIARY OF MICROCHIP TECHNOLOGY INC.)

14.18.1 COMPANY SNAPSHOT

14.18.2 REVENUE ANALYSIS

14.18.3 PRODUCT PORTFOLIO

14.18.4 RECENT DEVELOPMENTS

14.19 MICROTRANSPONDER INC

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENT

14.2 MICRO-LEADS

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

14.21 NALU MEDICAL, INC

14.21.1 COMPANY SNAPSHOT

14.21.2 PRODUCT PORTFOLIO

14.21.3 RECENT DEVELOPMENT

14.22 NEURONANO AB

14.22.1 COMPANY SNAPSHOT

14.22.2 PRODUCT PORTFOLIO

14.22.3 RECENT DEVELOPMENTS

14.23 NEURIMPULSE S.R.L.

14.23.1 COMPANY SNAPSHOT

14.23.2 PRODUCT PORTFOLIO

14.23.3 RECENT DEVELOPMENTS

14.24 NEWRONIKA S.P.A.

14.24.1 COMPANY SNAPSHOT

14.24.2 PRODUCT PORTFOLIO

14.24.3 RECENT DEVELOPMENTS

14.25 OPTOGENTECH GMBH.

14.25.1 COMPANY SNAPSHOT

14.25.2 PRODUCT PORTFOLIO

14.25.3 RECENT DEVELOPMENTS

14.26 ONWARD

14.26.1 COMPANY SNAPSHOT

14.26.2 PRODUCT PORTFOLIO

14.26.3 RECENT DEVELOPMENT

14.27 STIMWAVE LLC (2021)

14.27.1 COMPANY SNAPSHOT

14.27.2 PRODUCT PORTFOLIO

14.27.3 RECENT DEVELOPMENTS

14.28 SEQUANA MEDICAL NV (2021)

14.28.1 COMPANY SNAPSHOT

14.28.2 REVENUE ANALYSIS

14.28.3 PRODUCT PORTFOLIO

14.28.4 RECENT DEVELOPMENTS

14.29 VALENCIA TECHNOLOGIES

14.29.1 COMPANY SNAPSHOT

14.29.2 PRODUCT PORTFOLIO

14.29.3 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

表格列表

TABLE 1 NORTH AMERICA PREVALENCE OF OBESITY

TABLE 2 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 3 NORTH AMERICA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 NORTH AMERICA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 5 NORTH AMERICA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 6 NORTH AMERICA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 7 NORTH AMERICA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 8 NORTH AMERICA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 9 NORTH AMERICA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 10 NORTH AMERICA LEAD IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 11 NORTH AMERICA SPINAL CORD STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 12 NORTH AMERICA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, 2020-2029 (USD MILLION)

TABLE 13 NORTH AMERICA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 14 NORTH AMERICA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 15 NORTH AMERICA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 16 NORTH AMERICA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 17 NORTH AMERICA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 18 NORTH AMERICA BATTERY IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 19 NORTH AMERICA DEEP BRAIN STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 20 NORTH AMERICA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, 2020-2029 (USD MILLION)

TABLE 21 NORTH AMERICA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 22 NORTH AMERICA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 23 NORTH AMERICA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 24 NORTH AMERICA SACRAL NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 25 NORTH AMERICA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, 2020-2029 (USD MILLION)

TABLE 26 NORTH AMERICA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 27 NORTH AMERICA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 28 NORTH AMERICA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 29 NORTH AMERICA VAGUS NERVE STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 30 NORTH AMERICA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, 2020-2029 (USD MILLION)

TABLE 31 NORTH AMERICA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 32 NORTH AMERICA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 33 NORTH AMERICA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 34 NORTH AMERICA GASTRIC ELECTRICAL STIMULATION IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 35 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 36 NORTH AMERICA DIRECT TENDER IN INTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 NORTH AMERICA THIRD PARTY PROVIDER IN INTERNAL NEUROSTIMULATION DEVICES MARKET, 2020-2029 (USD MILLION)

TABLE 38 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 39 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 40 NORTH AMERICA SPINAL CORD STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 41 NORTH AMERICA BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 42 NORTH AMERICA BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 43 NORTH AMERICA BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 44 NORTH AMERICA LEAD IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA LEAD IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 46 NORTH AMERICA LEAD IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 47 NORTH AMERICA SPINAL CORD STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 48 NORTH AMERICA DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 49 NORTH AMERICA DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 50 NORTH AMERICA DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 51 NORTH AMERICA BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 52 NORTH AMERICA BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 53 NORTH AMERICA BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 54 NORTH AMERICA DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 55 NORTH AMERICA SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 NORTH AMERICA SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 57 NORTH AMERICA SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 58 NORTH AMERICA SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 59 NORTH AMERICA VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 60 NORTH AMERICA VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 61 NORTH AMERICA VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 62 NORTH AMERICA VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 63 NORTH AMERICA GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 64 NORTH AMERICA GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 65 NORTH AMERICA GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 66 NORTH AMERICA GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 67 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 68 U.S. NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 69 U.S. SPINAL CORD STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 70 U.S. BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 71 U.S. BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 72 U.S. BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 73 U.S. LEAD IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 74 U.S. LEAD IN N NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 75 U.S. LEAD IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 76 U.S. SPINAL CORD STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 77 U.S. DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 78 U.S. DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 79 U.S. DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 80 U.S. BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 81 U.S. BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 82 U.S. BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 83 U.S. DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 84 U.S. SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 85 U.S. SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 86 U.S. SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 87 U.S. SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 88 U.S. VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 89 U.S. VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 90 U.S. VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 91 U.S. VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 92 U.S. GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 93 U.S. GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 94 U.S. GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 95 U.S. GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 96 U.S. NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 97 CANADA NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 98 CANADA SPINAL CORD STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 99 CANADA BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 100 CANADA BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 101 CANADA BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 102 CANADA LEAD IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 103 CANADA LEAD IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 104 CANADA LEAD IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 105 CANADA SPINAL CORD STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 106 CANADA DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 107 CANADA DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 108 CANADA DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 109 CANADA BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 110 CANADA BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 111 CANADA BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 112 CANADA DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 113 CANADA SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 114 CANADA SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 115 CANADA SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 116 CANADA SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 117 CANADA VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 118 CANADA VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 119 CANADA VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 120 CANADA VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 121 CANADA GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 122 CANADA GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 123 CANADA GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 124 CANADA GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 125 CANADA NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 126 MEXICO NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 127 MEXICO SPINAL CORD STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 128 MEXICO BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 129 MEXICO BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 130 MEXICO BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 131 MEXICO LEAD IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 132 MEXICO LEAD IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 133 MEXICO LEAD IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 134 MEXICO SPINAL CORD STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 135 MEXICO DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 136 MEXICO DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 137 MEXICO DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 138 MEXICO BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 139 MEXICO BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 140 MEXICO BATTERY IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 141 MEXICO DEEP BRAIN STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 142 MEXICO SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 143 MEXICO SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 144 MEXICO SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 145 MEXICO SACRAL NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 146 MEXICO VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 147 MEXICO VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 148 MEXICO VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 149 MEXICO VAGUS NERVE STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 150 MEXICO GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 151 MEXICO GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (ASP)

TABLE 152 MEXICO GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 153 MEXICO GASTRIC ELECTRICAL STIMULATION IN NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 154 MEXICO NEUROSTIMULATION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: GEOGRAPHIC SCOPE

FIGURE 3 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: DATA TRIANGULATION

FIGURE 4 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: SNAPSHOT

FIGURE 5 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BOTTOM UP APPROACH

FIGURE 6 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: TOP DOWN APPROACH

FIGURE 7 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: INTERVIEWS BY REGION AND DESIGNATION

FIGURE 8 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: THE CATEGORY VS TIME GRID

FIGURE 10 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET SEGMENTATION

FIGURE 11 INCREASE IN PREVALENCE AND INCIDENCE OF NEUROLOGICAL DISEASES AND DEMAND FOR INTERNAL NEUROSTIMULATION DEVICES AS A ADD ON THERAPY ARE EXPECTED TO DRIVE THE NORTH AMERICA INTERNAL NEUROSTIMULATIOJ DEVICES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 SPINAL CORD STIMULATION IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET IN 2022 TO 2029

FIGURE 13 NORTH AMERICA INCIDENCE OF ISCHEMIA

FIGURE 14 NORTH AMERICA INCIDENCE OF PARKINSON'S DISEASES

FIGURE 15 NORTH AMERICA INCIDENCE OF TREMOR

FIGURE 16 NORTH AMERICA INCIDENCE RATE OF EPILEPSY

FIGURE 17 NORTH AMERICA INCIDENCE RATE OF GASTROPARESIS

FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET

FIGURE 19 INCIDENCE OF ADULT ONSET BRAIN DISORDERS IN THE U.S. IN 2021

FIGURE 20 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT TYPE, 2021

FIGURE 21 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)

FIGURE 22 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT TYPE, CAGR (2022-2029)

FIGURE 23 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 24 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 25 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 26 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 27 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 28 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: SNAPSHOT (2021)

FIGURE 29 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BY COUNTRY (2021)

FIGURE 30 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 31 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 32 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT TYPE (2022-2029)

FIGURE 33 NORTH AMERICA INTERNAL NEUROSTIMULATION DEVICES MARKET: COMPANY SHARE 2021 (%)

查看详细信息 Right Arrow

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外,市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息,请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量,其中包括数据挖掘、数据变量对市场影响的分析和主要(行业专家)验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息,请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制,包括目标品牌的价格趋势分析、了解其他国家的市场(索取国家列表)、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表(事实手册)中的数据,或者可以帮助您根据报告中的数据集创建演示文稿。

Testimonial